Retinal Degenerative Diseases: Mechanisms and Experimental Therapy (Advances in Experimental Medicine and Biology)

0 avg rating
( 0 ratings by Goodreads )
 
9781461432081: Retinal Degenerative Diseases: Mechanisms and Experimental Therapy (Advances in Experimental Medicine and Biology)
View all copies of this ISBN edition:
 
 

This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012).  A majority of those who will speak and present posters at the meeting will contribute to this volume.  The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70.  The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them.  Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the “best” and “most important” meetings in the field.

 

The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.

 

While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010.  These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials.

 

The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general.  It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS.  Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume.  We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.

"synopsis" may belong to another edition of this title.

Buy New View Book
List Price: US$ 419.00
US$ 324.85

Convert Currency

Shipping: FREE
From United Kingdom to U.S.A.

Destination, Rates & Speeds

Add to Basket

Top Search Results from the AbeBooks Marketplace

1.

Published by Springer-Verlag New York Inc., United States (2014)
ISBN 10: 1461432081 ISBN 13: 9781461432081
New Hardcover Quantity Available: 1
Seller:
Book Depository International
(London, United Kingdom)
Rating
[?]

Book Description Springer-Verlag New York Inc., United States, 2014. Hardback. Condition: New. 2014 ed.. Language: English . Brand New Book. This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the best and most important meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume. Seller Inventory # SPR9781461432081

More information about this seller | Contact this seller

Buy New
US$ 324.85
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

2.

John Ash (Editor), Joe G. Hollyfield (Editor), Matthew M. LaVail (Editor), Robert E. Anderson (Editor), Christian Grimm (Editor), Catherine Bowes Rickman (Editor)
Published by Springer (2013)
ISBN 10: 1461432081 ISBN 13: 9781461432081
New Hardcover Quantity Available: 1
Seller:
Ergodebooks
(RICHMOND, TX, U.S.A.)
Rating
[?]

Book Description Springer, 2013. Hardcover. Condition: New. 2013. Seller Inventory # SONG1461432081

More information about this seller | Contact this seller

Buy New
US$ 319.87
Convert Currency

Add to Basket

Shipping: US$ 4.99
Within U.S.A.
Destination, Rates & Speeds

3.

Published by Springer-Verlag New York Inc., United States (2014)
ISBN 10: 1461432081 ISBN 13: 9781461432081
New Hardcover Quantity Available: 1
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Springer-Verlag New York Inc., United States, 2014. Hardback. Condition: New. 2014 ed.. Language: English . Brand New Book. This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the best and most important meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume. Seller Inventory # SPR9781461432081

More information about this seller | Contact this seller

Buy New
US$ 346.49
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

4.

Joe G. Hollyfield
Published by Springer-Verlag New York Inc. (2014)
ISBN 10: 1461432081 ISBN 13: 9781461432081
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description Springer-Verlag New York Inc., 2014. HRD. Condition: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # IQ-9781461432081

More information about this seller | Contact this seller

Buy New
US$ 380.00
Convert Currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, Rates & Speeds

5.

Published by Springer (2014)
ISBN 10: 1461432081 ISBN 13: 9781461432081
New Hardcover Quantity Available: 1
Seller:
Irish Booksellers
(Portland, ME, U.S.A.)
Rating
[?]

Book Description Springer, 2014. Condition: New. book. Seller Inventory # M1461432081

More information about this seller | Contact this seller

Buy New
US$ 386.51
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

6.

Ash, John
Published by Springer (2016)
ISBN 10: 1461432081 ISBN 13: 9781461432081
New Paperback Quantity Available: 1
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description Springer, 2016. Paperback. Condition: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Seller Inventory # ria9781461432081_lsuk

More information about this seller | Contact this seller

Buy New
US$ 386.06
Convert Currency

Add to Basket

Shipping: US$ 5.40
From United Kingdom to U.S.A.
Destination, Rates & Speeds

7.

Ash, John (Editor)/ Hollyfield, Joe G. (Editor)/ Lavail, Matthew M. (Editor)/ Anderson, Robert E. (Editor)/ Grimm, Christian (Editor)
Published by Springer Verlag (2014)
ISBN 10: 1461432081 ISBN 13: 9781461432081
New Hardcover Quantity Available: 2
Seller:
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description Springer Verlag, 2014. Hardcover. Condition: Brand New. 2014 edition. 862 pages. 9.25x6.25x2.00 inches. In Stock. Seller Inventory # __1461432081

More information about this seller | Contact this seller

Buy New
US$ 441.23
Convert Currency

Add to Basket

Shipping: US$ 8.40
From United Kingdom to U.S.A.
Destination, Rates & Speeds

8.

John D. Ash (editor), Christian Grimm (editor), Joe G. Hollyfield (editor), Robert E. Anderson (editor), Matthew M. LaVail (editor), Catherine Bowes Rickman (editor)
Published by Springer New York 2014-03-25, New York (2014)
ISBN 10: 1461432081 ISBN 13: 9781461432081
New Hardcover Quantity Available: 10
Seller:
Blackwell's
(Oxford, OX, United Kingdom)
Rating
[?]

Book Description Springer New York 2014-03-25, New York, 2014. hardback. Condition: New. Seller Inventory # 9781461432081

More information about this seller | Contact this seller

Buy New
US$ 442.00
Convert Currency

Add to Basket

Shipping: US$ 8.40
From United Kingdom to U.S.A.
Destination, Rates & Speeds

9.

Published by Springer (2018)
ISBN 10: 1461432081 ISBN 13: 9781461432081
New Hardcover Quantity Available: 19
Print on Demand
Seller:
Murray Media
(North Miami Beach, FL, U.S.A.)
Rating
[?]

Book Description Springer, 2018. Hardcover. Condition: New. Never used! This item is printed on demand. Seller Inventory # 1461432081

More information about this seller | Contact this seller

Buy New
US$ 473.40
Convert Currency

Add to Basket

Shipping: US$ 1.99
Within U.S.A.
Destination, Rates & Speeds

10.

Published by Springer (2014)
ISBN 10: 1461432081 ISBN 13: 9781461432081
New Hardcover Quantity Available: 1
Seller:
Rating
[?]

Book Description Springer, 2014. Condition: New. Seller Inventory # L9781461432081

More information about this seller | Contact this seller

Buy New
US$ 479.04
Convert Currency

Add to Basket

Shipping: US$ 3.68
From Germany to U.S.A.
Destination, Rates & Speeds

There are more copies of this book

View all search results for this book